Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant adeno-associated viral vector containing the human CNGB3 gene

EU orphan designation number: EU/3/13/1099   
Active ingredient: Recombinant adeno-associated viral vector containing the human CNGB3 gene
Indication: Treatment of achromatopsia caused by mutations in the CNGB3 gene
Sponsor: TMC Pharma Services Ltd
Lodge Farm Barn, Elvetham Park Estate, Fleet Road, Hartley Wintney, Hampshire RG27 8AS, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/02/2013 Centralised Orphan - Designation EMA/OD/109/12 (2013)800 of 08/02/2013